⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANIX News
Anixa Biosciences, Inc.
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
prnewswire.com
ONCY
ANIX
ICCM
IBRX
REGN
ONCY
ANIX
ICCM
IBRX
REGN
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
prnewswire.com
ANIX
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
prnewswire.com
ANIX